773
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Patient and parent preferences for immunoglobulin treatments: a conjoint analysis

, , , &
Pages 1183-1191 | Accepted 13 Jul 2012, Published online: 09 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Paul M Overton, Natalie Shalet, Fabian Somers & Jeffrey A Allen. (2021) Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review. Patient Preference and Adherence 15, pages 811-834.
Read now
Heather L Gelhorn, Zaneta Balantac, Christopher S Ambrose, Yen N Chung & Brian Stone. (2019) Patient and physician preferences for attributes of biologic medications for severe asthma. Patient Preference and Adherence 13, pages 1253-1268.
Read now
Teresa Espanol, Johan Prevot, Jose Drabwell, Seema Sondhi & Laurence Olding. (2014) Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Preference and Adherence 8, pages 621-629.
Read now

Articles from other publishers (11)

Vincent Ebhabha, Hana Morrissey & Patrick Ball. (2023) Comparing Patient Preference Between At-home and In-hospital Settings: Systematic Review and Meta-Analysis on Injectable Medications. Archives of Pharmacy Practice 14:3, pages 98-111.
Crossref
Juan Marcos Gonzalez, Mark Ballow, Angelyn Fairchild & Michael Chris Runken. (2022) Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy. Frontiers in Immunology 13.
Crossref
Clémence Perraudin, Aline Bourdin, Alex Vicino, Thierry Kuntzer, Olivier Bugnon & Jérôme Berger. (2020) Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis. PLOS ONE 15:11, pages e0242630.
Crossref
Pieter van Paassen, David Pittrow, Clemens Scheidegger, Jens Klotsche & Pauline M Ellerbroek. (2020) Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patients. Immunotherapy 12:2, pages 131-139.
Crossref
Jeffrey A. Allen, Deborah F. Gelinas, Miriam Freimer, M. Chris Runken & Gil I. Wolfe. (2020) Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?. Journal of the Neurological Sciences 408, pages 116497.
Crossref
Christine Anterasian, Richard Duong, Peg Gruenemeier, Carol Ernst, Jessica Kitsen & Bob Geng. (2019) Quality of Life Differences for Primary Immunodeficiency Patients on Home SCIG versus IVIG. Journal of Clinical Immunology 39:8, pages 814-822.
Crossref
Marta Trapero-Bertran, Beatriz Rodríguez-Martín & Julio López-Bastida. (2019) What attributes should be included in a discrete choice experiment related to health technologies? A systematic literature review. PLOS ONE 14:7, pages e0219905.
Crossref
Georgina L. Jones, Katharina S. Vogt, Duncan Chambers, Mark Clowes & Anna Shrimpton. (2018) What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review. Frontiers in Immunology 9.
Crossref
Giuseppe Spadaro, Alessandra Vultaggio, A Alberto Bosi, Dietmar Reichert, Jan Janssen, Donatella Lamacchia, Liliana Nappi, Antonio Pecoraro, Cinzia Milito, Andrea Ferraro, Andrea Matucci, Francesca Bacchiarri, Valentina Carrai, Azra Hibbeler, Elisabet Speckman, Chiara Guarnieri, Serena Bongiovanni & Isabella Quinti. (2017) Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia. International Immunopharmacology 44, pages 38-42.
Crossref
Richard L. Wasserman, Diane Ito, Yan Xiong, Xiaolan Ye, Patrick Bonnet & Josephine Li-McLeod. (2017) Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy. Journal of Clinical Immunology 37:2, pages 180-186.
Crossref
Michael D. Clark, Domino Determann, Stavros Petrou, Domenico Moro & Esther W. de Bekker-Grob. (2014) Discrete Choice Experiments in Health Economics: A Review of the Literature. PharmacoEconomics 32:9, pages 883-902.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.